PRKN and Parkinson disease: According to previously published data, PD patients harboring PRKN mutations require a low LEDD for excellent control of motor signs, but despite receiving markedly low doses of levodopa, they exhibited the frequent development of motor complications and dyskinesias from early disease stages.